Wave Life Sciences
WVE
81 hedge funds and large institutions have $263M invested in Wave Life Sciences in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 17 closing their positions.
152% more call options, than puts
Call options by funds: $189K | Put options by funds: $75K
53% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 17
13% more funds holding
Funds holding: 72 → 81 (+9)
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
1.96% more ownership
Funds ownership: 71.4% → 73.36% (+2%)
13% less capital invested
Capital invested by funds: $303M → $263M (-$40.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$13M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.77M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.57M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.54M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$950K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.87M |
| 2 |
Millennium Management
New York
|
-$2.69M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$2.21M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.1M |
| 5 |
Jane Street
New York
|
-$1.61M |
WVE Hedge Fund Activity: Q2 2023 in Review
81 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2023, worth a combined $263M — down 13% from $303M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new WVE positions and 17 closed out — a net gain of 9 holders — while 21 added to existing stakes and 19 trimmed.
The largest buyer was BlackRock, adding an estimated $13M. The largest seller was Susquehanna International Group, cutting an estimated $2.87M.
- 81 institutional investors held Wave Life Sciences (WVE) as of Q2 2023, up from 72 in Q1 2023.
- Funds reported $263M of Wave Life Sciences stock for Q2 2023, down 13% quarter-over-quarter.
- 26 funds opened new Wave Life Sciences positions in Q2 2023 and 17 closed out, a net change of +9 holders.
- The largest Wave Life Sciences buyer in Q2 2023 was BlackRock, an estimated $13M added.
- The largest Wave Life Sciences seller in Q2 2023 was Susquehanna International Group, an estimated $2.87M sold.
Based on aggregated 13F filings for Q2 2023.